Similar to our previous studies, the mean tumor volume in IDO shRNA treated-groups was smaller than that in Scr IDO1shRNA-treated groups at day 16, post injection of LLC1 tumor cells (Figure 1b). Here, IDO1 is linked to neoplasm.